Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma

doi:10.3748/wjg.v25.i37.5604

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 25, Issue 37

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (6329)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Figures (1-3) series, Tables (1-8) series.

Item

Count

PDF

734

WORD

259

HTML

2855

Figures (1-3)

194

Tables (1-8)

160

Sum=4202

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

762

Download

1365

Sum=2127

Oct 7, 2019 (publication date) through Apr 26, 2024

Times Cited of This Article

Times Cited (17)

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Control Study

World J Gastroenterol. Oct 7, 2019; 25(37): 5604-5618
Published online Oct 7, 2019. doi: 10.3748/wjg.v25.i37.5604

Table 7 Predictive value of plasma miR-21 and miR-93 for the 3-year overall survival in esophageal squamous cell carcinoma patients

Index	AUC	95%CI	SE	Cut-off	Sensitivity (%)	Specificity (%)
MiR-21	0.861	0.797-0.926	0.033	5.60	82.50	79.17
MiR-93	0.807	0.733-0.880	0.037	3.87	62.50	92.50

AUC: Area under the receiver operating characteristic curve; CI: Confidence interval.

Citation: Wang WT, Guo CQ, Cui GH, Zhao S. Correlation of plasma miR-21 and miR-93 with radiotherapy and chemotherapy efficacy and prognosis in patients with esophageal squamous cell carcinoma. World J Gastroenterol 2019; 25(37): 5604-5618
URL: https://www.wjgnet.com/1007-9327/full/v25/i37/5604.htm
DOI: https://dx.doi.org/10.3748/wjg.v25.i37.5604